CD47 and cancer: If CD47 controls Cdc42 expression in NSCLC cells, and Cdc42 in turn mediates the invasive phenotype of these cancer cells, then blocking CD47 or inhibiting Cdc42 expression may become a new method of inhibiting the metastasis of NSCLC cells.